Phase I Studies of a Novel Pulsatile FXR Ligand for Treating Cholestatic Liver Diseases

linafexor (CS0159) - Cascade Pharma

Rong Deng 1; Jingjing Shi 1; Gaihong Wang 1; Guanguan Zhao 1; Hualing Pan 1; Shengsheng Yang 1; Zhenwei Zhang 1; Eric H Xu 1, 2

Feb 20, 2025